What is the share price of 2.50% Series IV FY 2022-23 (SGBMAR31IV)?

Company share prices are keep on changing according to the market conditions. The current trading price of 2.50% Series IV FY 2022-23 (SGBMAR31IV) on 13-Nov-2026 16:59:59 at 16:59 is 14150.00.

What is the P/E ratio of 2.50% Series IV FY 2022-23?

The latest standalone P/E ratio of 2.50% Series IV FY 2022-23 as of 13-Nov-2026 is .

What is the P/B ratio of 2.50% Series IV FY 2022-23 (SGBMAR31IV)?

The latest standalone P/B ratio of 2.50% Series IV FY 2022-23 (SGBMAR31IV) as of 13-Nov-2026 is .

What is the 52-week high and low of 2.50% Series IV FY 2022-23 (SGBMAR31IV)?

The 52-week high of 2.50% Series IV FY 2022-23 (SGBMAR31IV) is Rs. 19731.25 and the 52-week low is Rs. 13300.01.

What is the TTM revenue of 2.50% Series IV FY 2022-23 (SGBMAR31IV)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of 2.50% Series IV FY 2022-23 is Rs. (Cr.).

Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.

Received from

Pending at the end of last month

Received

Resolved*

Total Pending #

Pending complaints >3months

Average Resolution time^ (in days)

Directly from Investors

SEBI (SCORES)

Other Sources (if any)

Grand Total

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.

Month

Carried forward from previous month

Received

Resolved*

Pending#

Jun, 2026

Jul, 2026

Aug, 2026

Grand Total

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Sr. No.

Fin. Year

Carried forward from previous year

Received

Resolved*

Pending#

2022-23

2023-24

2024-25

2025-26

Grand Total

2.50% Series IV FY 2022-23 (SGBMAR31IV)

Name: 2.50% Series IV FY 2022-23 (SGBMAR31IV)
Brand: 2.50% Series IV FY 2022-23

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 800575 NSE: SGBMAR31IV Unspecified | | SGBMAR31 Share Price

₹14,150 -120.00 (-0.84%)

As on 13-Nov'26 16:59

2.50% Series IV FY 2022-23 (SGBMAR31IV)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 800575 NSE: SGBMAR31IV Unspecified | | SGBMAR31 Share Price

₹14,150 -120.00 (-0.84%)

As on 13-Nov'26 16:59

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹14,150

52-Week Low / High

₹13,300 / 19,731

TTM EPS

TTM Sales

Book Value per Share

P/E Ratio

Industry PE

Price to Book (P/B)

Price to Sales (P/S)

EV/EBITDA

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

Return on Capital Employed (ROCE)

Return on Assets (ROA)

Operating Profit Margin

Net Profit Margin

Gross Profit Margin

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

Equity

Face Value

All Time Low / High

- / -

2.50% Series IV FY 2022-23 stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Information and data for this Company is currently unavailable.
We assure our users that information and data for the company will be available soon.

Valuation of SGBMAR31 - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

No data found!

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Annual reports

No annual reports available.

Concalls

No concalls available.

2.50% Series IV FY 2022-23 FAQs

The current trading price of SGBMAR31 on 13-Nov-2026 16:59 is ₹14,150.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Nov-2026 the market cap of SGBMAR31 stood at ₹0.00 Cr

The latest P/E ratio of SGBMAR31 as of 12-Nov-2026 is 0.00.

The latest P/B ratio of SGBMAR31 as of 12-Nov-2026 is 0.00.

The 52-week high of SGBMAR31 is ₹19,731.3 and the 52-week low is ₹13,300.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of SGBMAR31 is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

About 2.50% Series IV FY 2022-23

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

2.50% Series IV FY 2022-23 (SGBMAR31IV)

2.50% Series IV FY 2022-23 (SGBMAR31IV)

2.50% Series IV FY 2022-23 stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Valuation of SGBMAR31 - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Annual reports

Concalls

2.50% Series IV FY 2022-23 FAQs

About 2.50% Series IV FY 2022-23

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

2.50% Series IV FY 2022-23 (SGBMAR31IV)

2.50% Series IV FY 2022-23 (SGBMAR31IV)

2.50% Series IV FY 2022-23 stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Valuation of SGBMAR31 - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Financials

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Annual reports

Concalls

2.50% Series IV FY 2022-23 FAQs

What is the share price of SGBMAR31?

What is the market cap of SGBMAR31?

What is the P/E ratio of SGBMAR31?

What is the P/B ratio of SGBMAR31?

What is the 52-week high and low of SGBMAR31?

What is the TTM revenue of SGBMAR31?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About 2.50% Series IV FY 2022-23